Each year, the Top 100 Swiss Startup Awards showcases the most promising Swiss start-ups. High-ranking start-ups on previous lists have achieved unicorn status and seen lucrative acquisitions, while this year’s cream of the crop have been making their own headlines.
“Many of the top 100 start-ups are already internationally sought-after technology and innovation partners, as well as attractive investment objects,” said Bastian Zarske Bueno, head of corporate ventures at Swiss Prime Site, of the 2019 ranking.
The Top 100 was selected by a jury of 100 investors and experts seeking Switzerland’s most impactful start-ups. Those at the very top highlight the attraction of health-focused innovators and disruptors as well as a strong showing for drone and autonomous vehicle technology.
A spin-out of EPFL, a research institute and university in Lausanne, Flyability builds drones especially for safe indoor use. These drones can then be used for the inspection and exploration of inaccessible or even hazardous spaces in nuclear, energy, chemical and mining industries. The company also works with search and rescue and security professionals with, more than 550 of its Elios drones deployed at more than 350 sites.
During ASME’s Robotics for Inspection and Maintenance Forum (September 23th – 24th), Flyability will present the Elios 2, and explain how it is becoming the standard for UAS RVI worldwide. https://t.co/oEGjWlUu7V
— Flyability (@fly_ability) September 10, 2019
Just last month, Bestmile announced a $16.5m Series B round led by Blue Lagoon Capital and TransLink Capital. “With these funds and leadership, we are ready to advance our leadership in fleet orchestration,” said co-founder and CEO Raphael Gindrat. “We are excited to have the financial and operational support we need to ramp up every function of the organisation.”
Completing the half-dozen best of Switerland’s start-ups is biotech Cutiss, currently trialling its method of growing large grafts of human skin in the lab for patients suffering from defects such as burns and trauma. Cutiss bio-engineers skin from a small, healthy patient sample, extracting and expanding the cells to bio-engineer skin that closely resembles human skin.
Once again proving the pedigree of Switzerland’s university spin-outs, Cutiss comes from the University of Zurich. CEO and co-founder Daniela Marino said, “In 2012 we received 9m Swiss francs from the EU to run clinical trials and, when I saw that the first results were good, I decided to start a company to acquire more funds in order to take the project all the way to the market. I was on an academic path and gave myself three months to test my business idea, and here I am!”
Want stories like this and more direct to your inbox? Sign up for Tech Trends, Silicon Republic’s weekly digest of need-to-know tech news.
Source:: Silicon Republic